DR. JOSEPH VINCENT DITROLIO, M.D.
Urology at Eagle Rock Ave, Roseland, NJ
License number
New Jersey 25MA03785200
Category
Radiology
Type
Urology
Address
Address
556 Eagle Rock Ave SUITE 204, Roseland, NJ 07068
Phone
(973) 228-2771
(973) 228-7477 (Fax)
(973) 228-7477 (Fax)
Professional information
Joseph Vincent Ditrolio, Roseland NJ
Specialties:
Urologist
Address:
556 Eagle Rock Ave, Roseland, NJ 07068
Education:
University of Medicine and Dentistry of New Jersey, New Jersey Medical School - Doctor of Medicine
Board certifications:
American Board of Urology Certification in Urology
Chemoablation Of Tissue Using Biodegradable, Solid Salt Dosage Forms
US Patent:
8057827, Nov 15, 2011
Filed:
Jun 4, 2007
Appl. No.:
11/810075
Inventors:
Joseph V. DiTrolio - Roseland NJ, US
Assignee:
Boston Scientific Scimed, Inc. - Maple Grove MN
International Classification:
A61K 51/00, A61K 33/14, A61F 2/00, A61M 36/14, A01N 59/08
US Classification:
424680, 424 125, 424426
Abstract:
Novel methods for the chemical ablation of tissue (e. g. prostatic tissue) are described. These methods include the steps of: (a) providing one or more solid salt dosage forms comprising 50-100% w/w salt; and (b) inserting one or more of such solid salt dosage forms into the tissue. The solid salt dosage forms is optionally inserted into the tissue under real-time ultrasonic observation. An advantage of the present invention is its ability to eliminate toxic byproducts. For example, where NaCl-based solid salt dosage forms are used to effect localized chemical ablation, the concentration is ultimately reduced to the level of normal saline (i. e. , about 0. 9%) upon absorption by the body of the subject being treated.
Chemoablation Of Tissue Using Biodegradable, Solid Salt Dosage Forms
US Patent:
8389023, Mar 5, 2013
Filed:
Sep 23, 2011
Appl. No.:
13/241952
Inventors:
Joseph V. DiTrolio - Roseland NJ, US
Assignee:
Boston Scientific Scimed, Inc. - Maple Grove MN
International Classification:
A61K 33/14, A61B 17/42, A61M 5/178, A61M 31/00, A61M 25/06, A61M 5/315
US Classification:
424680, 604 28, 604 36, 604 38, 604 44, 604 48, 604 57, 604 59, 604 60, 604 62, 604 64, 604264, 604272, 606272
Abstract:
Novel methods for the chemical ablation of tissue (e. g. prostatic tissue) are described. These methods include the steps of: (a) providing one or more solid salt dosage form comprising 50-100% w/w salt; and (b) inserting one or more of such solid salt dosage forms into the tissue. The solid salt dosage form is optionally inserted into the tissue under real-time ultrasonic observation. An advantage of the present invention is its ability to eliminate toxic byproducts. For example, where NaCl-based solid salt dosage forms are used to effect localized chemical ablation, the concentration is ultimately reduced to the level of normal saline (i. e. , about 0. 9%) upon absorption by the body of the subject being treated.
Chemoablation Of Tissue Using Biodegradable, Solid Salt Dosage Forms
US Patent:
2005006, Mar 24, 2005
Filed:
Sep 14, 2004
Appl. No.:
10/940589
Inventors:
Joseph DiTrolio - Roseland NJ, US
International Classification:
A61K033/14
US Classification:
424680000
Abstract:
Novel methods for the chemical ablation of tissue (e.g. prostatic tissue) are described. These methods include the steps of: (a) providing one or more solid salt dosage form comprising 50-100% w/w salt; and (b) inserting one or more of such solid salt dosage forms into the tissue. The solid salt dosage form is optionally inserted into the tissue under real-time ultrasonic observation. An advantage of the present invention is its ability to eliminate toxic byproducts. For example, where NaCl-based solid salt dosage forms are used to effect localized chemical ablation, the concentration is ultimately reduced to the level of normal saline (i.e., about 0.9%) upon absorption by the body of the subject being treated.
Methods And Compositions For Treating Urogenital Disorders
US Patent:
2010021, Aug 19, 2010
Filed:
Feb 18, 2010
Appl. No.:
12/708083
Inventors:
Alan E. KLIGERMAN - Egg Harbor Township NJ, US
Joseph V. DITROLIO - Roseland NJ, US
Joseph V. DITROLIO - Roseland NJ, US
Assignee:
PRELIEF INC. - Egg Harbor Township NJ
International Classification:
A61K 31/661, A61M 31/00, A61M 25/00, A61K 9/02, A61M 29/00, A61F 2/04, A61B 1/307, A61P 15/00
US Classification:
514129, 604514, 604523, 604288, 604 9601, 623 237, 600135
Abstract:
Glycerophosphate salts have been found to drastically improve the treatment of urogenital disorders such as urethral strictures and vaginal atrophy. Methods, devices and kits are described for treating urogenital disorders using a composition comprising an effective amount of a glycerophosphate salt.
Fluid Volume Alarm System
US Patent:
2011030, Dec 15, 2011
Filed:
Jun 14, 2010
Appl. No.:
12/814898
Inventors:
TODD A. LINSENMEYER - Mountain Lakes NJ, US
Joseph V. DiTrolio - Roseland NJ, US
Dorothy F. Linsenmeyer - Mountain Lakes NJ, US
Joseph V. DiTrolio - Roseland NJ, US
Dorothy F. Linsenmeyer - Mountain Lakes NJ, US
International Classification:
G08B 21/00
US Classification:
340612
Abstract:
A fluid volume alarm system is presented. The alarm system has a container for storing fluid, and alarm module coupled to the container for notifying a user or observer that the fluid within the container has reached a predetermined level. The container has at least one exterior wall and defines an interior volume for at least temporary storage of fluid. In one aspect, there are at least two electrodes disposed on an interior portion of the exterior wall of the container and positioned at a position thereon an interior portion of the exterior wall corresponding to a predetermined fluid level at which it is desirable to receive an alarm. The system also has an alarm module configured to alert the practitioner that the fluid has met or has exceeded the predetermined level.